Literature DB >> 7075035

Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal.

M K Chan, Z Varghese, J W Persaud, R A Baillod, J F Moorhead.   

Abstract

A study was undertaken in 76 patients on maintenance hemodialysis and 26 patients on maintenance peritoneal dialysis to elucidate the pathogenesis of hyperlipidemia in these patients. A high prevalence of hypertriglyceridemia and low concentrations of high density lipoprotein cholesterol was found. Hemodialysis patients had low or normal total cholesterol concentrations which were significantly lower than those on peritoneal dialysis. The length of treatment did not affect the prevalence of the lipid abnormalities. Both pre- and post-heparin fractional clearance rates of Intralipid were markedly reduced in both groups of dialysis patients and were correlated inversely with serum triglyceride concentrations. However, when compared with normal subjects with similar fractional clearance rates of Intralipid, both groups of dialysis patients had higher serum triglyceride concentrations, probably reflecting increased triglyceride production. Serum triglyceride concentrations in both groups of dialysis patients were positively correlated with plasma immunoreactive insulin levels. Furthermore, a significant inverse correlation was observed between plasma immunoreactive insulin levels and post-heparin fractional clearance rates of intralipid. It was concluded that insulin resistance probably caused the defective triglyceride removal, and that both decreased removal and increased production of triglycerides contributed to the hyperlipidemia in dialysis patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075035

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  [The effect of highly unsaturated fatty acids on the parameters of lipoprotein metabolism and rheology during their administration to patients undergoing chronic hemodialysis treatment].

Authors:  Y Schmitt; H Schneider
Journal:  Z Ernahrungswiss       Date:  1993-09

2.  Association between sympathetic activity and the atherogenic serum cholesterol fraction.

Authors:  P Weidmann; D C Schohn; W Riesen; H A Jahn; P Ferrari; S G Shaw; C Beretta-Piccoli
Journal:  Klin Wochenschr       Date:  1990-03-05

3.  The short term effects of bezafibrate on the hypertriglyceridaemia of moderate to severe uraemia.

Authors:  A J Williams; F Baker; J Walls
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

4.  Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy.

Authors:  M Antikainen
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

Review 5.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

Review 6.  Disturbances of lipid metabolism in children with chronic renal failure.

Authors:  U Querfeld
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.